SUBSIDIARIES

12 Months Ended

Jun. 30, 2024

Notes and other explanatory information [abstract]

SUBSIDIARIES

31. SUBSIDIARIES

The following diagram is a depiction of the Company structure as at June 30, 2024.

	Incorporation	Company interest (%)						Net carrying value (A$)
Name of Company	details	2024			2023			2024		2023
Entities held directly by parent
GeneType Pty. Ltd. (Dormant)	September 5, 1990 Victoria, Australia		100	%		100	%		-		-
Genetic Technologies Corporation Pty. Ltd. (Genetic testing)	October 11, 1996 NSW, Australia		100	%		100	%		2		2
Gene Ventures Pty. Ltd. (1) (Dormant)	March 7, 2001 NSW, Australia		100	%		100	%		10		10
GeneType Corporation (Dormant)	December 18, 1989 California, U.S.A.		100	%		100	%		-		-
geneType Inc. (2) (formerly Phenogen Sciences Inc.)	June 28, 2010 Delaware, U.S.A.		100	%		100	%		30,779,326		11,006
Hainan Aocheng Gene Technology Co Ltd	March 18, 2019 Hainan, China		100	%		100	%		-		-
Genetic Technologies HK Ltd	March 18, 2019 Hong Kong, China		100	%		100	%		-		-
Helix Genetics Limited	July 7, 2021 Malta		100	%		100	%		1,928		1,910
Genetype UK Limited	April 26, 2022 United Kingdom		100	%		100	%		190		176
Total carrying value									30,781,456		13,104

(1)	On 26 April 2018, the name of RareCellect Pty Ltd (ACN 096 135 9847) was changed to Gene Ventures Pty Ltd (ACN 096 135 947)
(2)	On 3 April 2023, the name of Phenogen Sciences Inc. was changed to geneType Inc.